Very comparable results were shown years ago with 5α-reductase inhibitors, e.g. in REDEEM trial https://t.co/fXeyzskGcg Several advantages of deferred treatment are gone when patients with low risk prostate cancer get a drug like enzalutamide.
68 followers
93 followers
@drsierrasierra https://t.co/SrkoPY8ZrL i think that REDEEM trial in this seeting might be a nice option on AS
598 followers
@ChapinMD @urogeek We actually have randomized data for 5ARI use in AS population. I routinely suggest taking a 5ARI for someone on surveillance to improve the accuracy of PSA and increase likelihood of subsequent negative surveillance biopsy. https://t.co
18 followers
RT @docfak: #ECNiBlanc2018 LCA 1 : Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-contr…